The ongoing COVID-19 pandemic has been spreading rapidly, causing almost a million deaths from nearly 33 million reported infections. Scientists are eager to identify risk factors for increased ...
Second Product Offering to Expand Disease Management within Enzo’s Comprehensive COVID-19 Program Enzo’s ELISA Kit for SARS-CoV-2 IgG Antibody Demonstrates High Specificity and High Sensitivity ...
REHOVOT, Israel, March 31, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced top-line results from its Phase 1/2 open-label, ...
REHOVOT, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced the completion of enrollment and initial interim ...
The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen). The Food and Drug Administration (FDA) ...
News-Medical.Net on MSN
COVID-19 immunity stays specific and barely boosts protection against common cold coronaviruses
This study shows that SARS-CoV-2 infection and vaccination generate strong, highly specific spike-binding immune responses ...
COVID-19 has spurred the development of a plethora of tests from various manufacturers. While molecular tests and rapid antigen tests are targeted for early diagnosis, serology tests play a different ...
Three new reports show coronavirus immunity can last for months – and maybe even longer. The findings suggest that many, if not most, people who recover from coronavirus infections are protected for ...
A new study finds therapies used to treat lupus (mycophenolate mofetil (CellCept®), tacrolimus (Protopic®), and belimumab (Benlysta®) significantly reduce a person’s response to the COVID-19 vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback